Improvement in clinical outcomes of patients with heart failure and active cocaine use after β‐blocker therapy

BACKGROUND: Cocaine use has a high prevalence in the United States and can be associated with significant cardiovascular disease, even in asymptomatic users. β‐Adrenergic receptor hyperactivation is the underlying pathophysiologic pathway of cocaine cardiotoxicity. β‐Blocker therapy is controversial...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Cardiol
Egile Nagusiak: Lopez, Persio D., Akinlonu, Adedoyin, Mene‐Afejuku, Tuoyo O., Dumancas, Carissa, Saeed, Mohammed, Cativo, Eder H., Visco, Ferdinand, Mushiyev, Savi, Pekler, Gerald
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wiley Periodicals, Inc. 2018
Gaiak:
Clinical Investigations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489838/
https://ncbi.nlm.nih.gov/pubmed/29663434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22897
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak